Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Undisclosed
Sponsor : Arch Ventures
Deal Size : $60.7 million
Deal Type : Series A Financing
Details : SonoThera’s ultrasound-guided platform uses sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads of diverse formats and sizes, selectively targeting a wide range of organs within the body.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 12, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Sponsor : Arch Ventures
Deal Size : $60.7 million
Deal Type : Series A Financing